Sensus Healthcare ROA 2014-2024 | SRTS
Current and historical return on assets (ROA) values for Sensus Healthcare (SRTS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Sensus Healthcare ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-06-30 | $0.01B | $0.06B | 12.73% |
| 2024-03-31 | $0.01B | $0.06B | 9.35% |
| 2023-12-31 | $0.00B | $0.05B | 1.90% |
| 2023-09-30 | $0.00B | $0.05B | 0.00% |
| 2023-06-30 | $0.00B | $0.05B | 5.53% |
| 2023-03-31 | $0.01B | $0.05B | 12.67% |
| 2022-12-31 | $0.03B | $0.06B | 45.05% |
| 2022-09-30 | $0.03B | $0.06B | 54.82% |
| 2022-06-30 | $0.03B | $0.06B | 59.52% |
| 2022-03-31 | $0.02B | $0.05B | 60.87% |
| 2021-12-31 | $0.00B | $0.03B | 14.55% |
| 2021-09-30 | $0.00B | $0.03B | 0.00% |
| 2021-06-30 | $-0.00B | $0.03B | -7.41% |
| 2021-03-31 | $-0.01B | $0.03B | -17.86% |
| 2020-12-31 | $-0.01B | $0.03B | -27.12% |
| 2020-09-30 | $-0.01B | $0.03B | -25.20% |
| 2020-06-30 | $-0.01B | $0.03B | -20.74% |
| 2020-03-31 | $-0.00B | $0.03B | -11.35% |
| 2019-12-31 | $-0.00B | $0.04B | -5.59% |
| 2019-09-30 | $-0.00B | $0.04B | -8.63% |
| 2019-06-30 | $-0.00B | $0.04B | -5.88% |
| 2019-03-31 | $-0.00B | $0.03B | -10.00% |
| 2018-12-31 | $-0.00B | $0.03B | -7.55% |
| 2018-09-30 | $-0.00B | $0.03B | -8.70% |
| 2018-06-30 | $-0.00B | $0.02B | -15.58% |
| 2018-03-31 | $-0.00B | $0.02B | -15.79% |
| 2017-12-31 | $-0.00B | $0.02B | -21.33% |
| 2017-09-30 | $-0.00B | $0.02B | -21.33% |
| 2017-06-30 | $-0.00B | $0.02B | -16.00% |
| 2017-03-31 | $-0.00B | $0.02B | -10.39% |
| 2016-12-31 | $0.00B | $0.02B | 0.00% |
| 2016-09-30 | $0.00B | $0.02B | 0.00% |
| 2016-06-30 | $0.00B | $0.02B | 0.00% |
| 2016-03-31 | $0.00B | $0.01B | 0.00% |
| 2015-12-31 | $-0.00B | $0.01B | -40.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.107B | $0.024B |
| Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
| Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
| Alcon (ALC) | Switzerland | $48.180B | 33.92 |
| IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
| Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
| IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
| DexCom (DXCM) | United States | $27.786B | 39.62 |
| STERIS (STE) | Ireland | $23.777B | 27.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
| Waters (WAT) | United States | $20.560B | 30.65 |
| Hologic (HOLX) | United States | $18.870B | 20.52 |
| Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
| Teleflex (TFX) | United States | $11.552B | 17.96 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
| Globus Medical (GMED) | United States | $9.844B | 27.54 |
| Penumbra (PEN) | United States | $7.859B | 81.58 |
| Glaukos (GKOS) | United States | $7.357B | 0.00 |
| Masimo (MASI) | United States | $6.252B | 33.48 |
| TransMedics (TMDX) | United States | $5.606B | 240.09 |
| Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
| PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
| Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
| Inari Medical (NARI) | United States | $2.519B | 0.00 |
| Veracyte (VCYT) | United States | $2.423B | 150.24 |
| Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
| RxSight (RXST) | United States | $2.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
| OPKO Health (OPK) | United States | $1.172B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
| Artivion (AORT) | United States | $1.137B | 104.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
| Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
| Paragon 28 (FNA) | United States | $0.695B | 0.00 |
| SiBone (SIBN) | United States | $0.693B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| IRadimed (IRMD) | United States | $0.595B | 32.16 |
| AxoGen (AXGN) | United States | $0.576B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
| Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
| Inogen (INGN) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.137B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |